These results suggest that blocking IL-6/Gp130/STAT3-MYC axis by PS-Gp130 and PS-MYC peptides can induce PDAC tumor regression through both antiproliferation/survival of tumor cells and induction of antitumor immune responses. The gene discussed is MYC; the disease is neoplasm.